Evan G. Dick - Oct 19, 2021 Form 3/A - Amendment Insider Report for Context Therapeutics Inc. (CNTX)

Role
SVP of R&D
Signature
/s/ Alex Levit, Attorney-in-Fact
Stock symbol
CNTX
Transactions as of
Oct 19, 2021
Transactions value $
$0
Form type
3/A - Amendment
Date filed
12/17/2021, 03:10 PM
Date Of Original Report
Oct 19, 2021
Next filing
Oct 25, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CNTX Common Stock 56.4K Oct 19, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 33,397 restricted stock units which fully vest on January 31, 2023.

Remarks:

The numbers in Table 1 and the footnote thereto (including the date in the footnote) in this Form are to correct the respective numbers filed in the original Form 3 on October 19, 2021.